Research and Development Division, Super Religare Laboratories Ltd., Mumbai, India.
Leuk Lymphoma. 2011 May;52(5):865-76. doi: 10.3109/10428194.2011.552137.
Mutations of the WT1 gene have been reported as the most common abnormality after NPM1 and FLT3 gene mutations in acute myeloid leukemia (AML), while KIT mutations are predominantly found in core-binding factor (CBF) AMLs. We report for the first time the prevalence and distribution patterns of WT1 and KIT mutations in an Indian population of 150. Overall, 10 (6.7%) and four (2.7%) of the cases had WT1 and KIT mutations, respectively. Of the six mutations observed in exon 7, five were frameshift while the remaining one case showed a substitution mutation. In contrast to exon 7, no frameshift mutation was detected in exon 9, where all mutations were substitution mutations. Interestingly, we observed a novel mutation in exon 8 of the KIT gene resulting from the deletion of nine nucleotides and insertion of three nucleotides affecting the extracellular domain of the KIT receptor, while Asp816Tyr and Asp816His were commonly found in exon 17 of the KIT gene. The WT1 mutation was more prevalent in normal karyotype AML while KIT was associated with t(8;21). With respect to FLT3 and NPM1 mutations, WT1 was more predominant in FLT3 positive cases and less in NPM1 mutation cases, while no KIT mutation was found in FLT3/NPM1 positive cases.
WT1 基因突变是急性髓系白血病(AML)继 NPM1 和 FLT3 基因突变之后最常见的异常,而 KIT 基因突变主要发生在核心结合因子(CBF)AML 中。我们首次报道了 WT1 和 KIT 基因突变在印度人群中的流行率和分布模式,该人群共纳入 150 例患者。总的来说,WT1 和 KIT 基因突变分别见于 10(6.7%)例和 4(2.7%)例患者。在观察到的 6 个 7 号外显子突变中,有 5 个是移码突变,而其余 1 例为取代突变。与 7 号外显子不同,9 号外显子未检测到移码突变,所有突变均为取代突变。有趣的是,我们观察到 KIT 基因 8 号外显子的一个新突变,该突变由 9 个核苷酸缺失和 3 个核苷酸插入引起,影响 KIT 受体的细胞外结构域,而 Asp816Tyr 和 Asp816His 常见于 KIT 基因的 17 号外显子。WT1 突变在正常核型 AML 中更为常见,而 KIT 与 t(8;21)相关。就 FLT3 和 NPM1 突变而言,WT1 在 FLT3 阳性病例中更为常见,在 NPM1 突变病例中则较少,而在 FLT3/NPM1 阳性病例中未发现 KIT 突变。